Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Return on Sales: 2011-2025

Historic Return on Sales for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to 0.10%.

  • Mimedx Group's Return on Sales rose 10.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year increase of 10.00%. This contributed to the annual value of 0.00% for FY2024, which is 3.00% up from last year.
  • Mimedx Group's Return on Sales amounted to 0.10% in Q3 2025, which was up 55.37% from 0.07% recorded in Q2 2025.
  • Mimedx Group's 5-year Return on Sales high stood at 0.10% for Q3 2025, and its period low was -0.21% during Q1 2021.
  • Over the past 3 years, Mimedx Group's median Return on Sales value was 0.01% (recorded in 2024), while the average stood at 0.01%.
  • Examining YoY changes over the last 5 years, Mimedx Group's Return on Sales showed a top increase of 15bps in 2021 and a maximum decrease of 16bps in 2021.
  • Mimedx Group's Return on Sales (Quarterly) stood at -0.05% in 2021, then dropped by 2bps to -0.07% in 2022, then rose by 5bps to -0.03% in 2023, then grew by 5bps to 0.02% in 2024, then climbed by 10bps to 0.10% in 2025.
  • Its Return on Sales stands at 0.10% for Q3 2025, versus 0.07% for Q2 2025 and 0.04% for Q1 2025.